HTAtlas
← Back to explore

Cochrane Risk of Bias Tool

Toolpeer-reviewed

This tool helps assess how reliable a clinical trial is by checking for flaws in its design, conduct, and reporting that might distort the results.

At a glance

Use when

Assessing the methodological quality of randomized controlled trials in systematic reviews.

Avoid when

Evaluating non-randomized studies or when detailed trial information is unavailable.

Inputs

Full trial reports, protocols, and supplementary materials for randomized trials.

Outputs

Risk of bias judgments across six domains, often visualized in summary and graph format.

How it works

The Cochrane Risk of Bias Tool evaluates seven key domains—random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective reporting, and other biases—to determine the risk of bias in randomized controlled trials. Each domain is judged as low, high, or unclear risk of bias to inform the credibility of trial findings.

HTA domains
Clinical Effectiveness, Safety
Assumptions
Bias can systematically distort effect estimates; domain-based assessment improves consistency and transparency in evaluating trial quality.
Strengths
Standardized and systematic approach to bias assessment,Widely adopted in systematic reviews and meta-analyses,Improves transparency and reproducibility of quality appraisal
Limitations
Subjective judgments may vary between reviewers,Limited guidance on how to combine domain-level judgments into an overall risk of bias score,Designed for randomized trials only
Also known as
RoB 1, Cochrane Risk of Bias Tool version 1, Cochrane Collaboration's risk of bias tool

Questions this answers

References & sources

Related methods

Similar by meaning

Beta record. Based on the original catalogue summary; primary-source enrichment pending.